Dystrophic muscle distribution in late-stage muscular dystrophy
Celeste Michelle Pilato; Melissa Sue Walker; Andrea M. Nguyen; McKay Elizabeth Hanna; Scott Lanxing Huang; Erika Morgan Lutins; M. Alex Meredith; Peter Jacob Haar; Mathula Thangarajh; Hope Theresa Richard; Woon Nam Chow
Abstract
Keywords
References
1 Theadom A, Rodrigues M, Roxburgh R, et al. Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 2014;43(3-4):259-68.
2 Brancaccio A. A molecular overview of the primary dystroglycanopathies. J Cell Mol Med. 2019;23(5):3058-62.
3 Mercuri E, Muntoni F. Muscular dystrophies. Lancet. 2013;381(9869):845-60.
4 Bushby KM. Dysferlin and muscular dystrophy. Acta Neurol Belg. 2000;100(3):142-5. PMid:11098285.
5 Diaz-Manera J, Fernandez-Torron R, LLauger J, et al. Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials. J Neurol Neurosurg Psychiatry. 2018;89(10):1071-81.
6 Umakhanova ZR, Bardakov SN, Mavlikeev MO, et al. Twenty-year clinical progression of dysferlinopathy in patients from dagestan. Front Neurol. 2017;8:77.
7 Waldrop MA, Flanigan KM. Update in Duchenne and Becker muscular dystrophy. Curr Opin Neurol. 2019;32(5):722-7.
8 National Institute of Dental and Craniofacial Research – NIDCR. Human subjects research overview [Internet]. 2020 [cited 2020 May 26]. Available from:
9 Saito M, Kawai H, Adachi K, Akaike M. Clinical feature and mechanism of cardiac failure in patients with Becker muscular dystrophy. Rinsho Shinkeigaku. 1994;34(2):134-40. PMid:8194265.
10 Nigro G, Comi LI, Politano L, Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol. 1990;26(3):271-7.
11 McDonald CM, Abresch RT, Carter GT, Fowler WM Jr, Johnson ER, Kilmer DD. Profiles of neuromuscular diseases. Becker’s muscular dystrophy. Am J Phys Med Rehabil. 1995;74(5, Suppl):S93-103.
Submitted date:
05/26/2020
Accepted date:
08/02/2020
Publication date:
11/20/2020